Document is current
Any future updates will be listed below
-
Authors
Zelizer, Sophia
Gallagher, Grace B.
Gonen, Mithat
Dang, Chau
Modi, Shanu
Chandarlapaty, Sarat
Drago, Joshua Z.
- License Information
-
More Information
Article History
Received: 23 May 2025
Accepted: 8 October 2025
First Online: 27 November 2025
Declarations
:
: JZD has received institutional grants/funding from Merck, AstraZeneca, Bolt Therapeutics, Jazz Pharmaceutics, and Orum therapeutics and has performed consulting/advisory work for AstraZeneca, Genagon, AmMax Bio, NuProbe, Revelio Therapeutics, MEDACorp, and BAIRD conferences. SC has received institutional grants/funding from Daiichi-Sankyo and AstraZeneca, share options in Totus Medicines, and consultation/Ad board/Honoraria from Daiichi-Sankyo, AstraZeneca, Lilly, Casdin Capital, and Pathos AI. CD has performed consulting/advisory work for Pfizer, Novartis, and Daiichi-Sankyo. SM has received institutional grants/funding from Duality, Biontech, Avacta, Genentech, Daiichi-Sankyo, AstraZeneca, Pfizer, Seagen, D3 Bio and Nuvanation, and consultation/Ad board/Honoraria from Genentech, Daiichi-Sankyo, AstraZeneca, Pfizer, Gilead, Boehringer, Avacta, and Biontech.
: The MSK Institutional Review Board on Human Research approved the study. This study complied with all relevant ethical regulations regarding patient data, in line with ethical norms and standards in the Declaration of Helsinki.
